MAP kinase/ERK kinase 1 (MEK1) phosphorylates regulator of calcineurin 1 (RCAN1) to regulate neuronal differentiation

J Cell Physiol. 2022 Feb;237(2):1406-1417. doi: 10.1002/jcp.30609. Epub 2021 Oct 14.

Abstract

Regulator of calcineurin 1 (RCAN1) is located close to the Down syndrome critical region (DSCR) on human chromosome 21 and is related to the Down syndrome (DS) phenotype. To identify a novel binding partner of RCAN1, we performed yeast two-hybrid screening and identified mitogen-activated protein (MAP) kinase/extracellular signal-regulated kinase (ERK) kinase 1 (MEK1) as a partner. MEK1 was able to bind and phosphorylate RCAN1 in vitro and in vivo. MEK1-dependent RCAN1 phosphorylation caused an increase in RCAN1 expression by increasing the protein half-life. Nerve growth factor (NGF)-dependent activation of the MEK1 pathway consistently induced RCAN1 expression. Moreover, we found that RCAN1 overexpression inhibited NGF-induced neurite outgrowth and expression of neuronal marker genes, such as growth cone-associated protein 43 (GAP43) and synapsin I, via inhibition of MEK1-ERK1/2 pathways. Our findings provide evidence that MEK1-dependent RCAN1 phosphorylation acts as an important molecular mechanism in the control of neuronal differentiation.

Keywords: Down syndrome; MEK1; NGF; RCAN1; differentiation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Calcineurin* / metabolism
  • Intracellular Signaling Peptides and Proteins / metabolism
  • MAP Kinase Kinase 1 / genetics
  • MAP Kinase Kinase 1 / metabolism
  • Nerve Growth Factor* / metabolism
  • Phosphorylation
  • Transcription Factors / metabolism

Substances

  • Intracellular Signaling Peptides and Proteins
  • Transcription Factors
  • Nerve Growth Factor
  • MAP Kinase Kinase 1
  • Calcineurin